Kitov Pharma Ltd (KTOV) Stock Price & Overview

NASDAQ:KTOV

4.17
+0.09 (+2.21%)
At close: Dec 21, 2020
4.11
-0.06 (-1.44%)
After Hours: 12/21/2020, 8:00:01 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

The current stock price of KTOV is 4.17 null. Today KTOV is up by 2.21%. In the past month the price increased by 2.71%. In the past year, price decreased by -45.12%.

KTOV Key Statistics

52-Week Range2.2 - 14.4
Current KTOV stock price positioned within its 52-week range.
1-Month Range3.925 - 4.42
Current KTOV stock price positioned within its 1-month range.
Market Cap
65.573M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-3.00
Dividend Yield
N/A

KTOV Stock Performance

Today
+2.21%
1 Week
+1.21%
1 Month
+2.71%
3 Months
+2.71%
Longer-term
6 Months -64.05%
1 Year -45.12%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

KTOV Stock Chart

Kitov Pharma Ltd / KTOV Daily stock chart

KTOV Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to KTOV. When comparing the yearly performance of all stocks, KTOV is a bad performer in the overall market: 94.86% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating
KTOV Full Technical Analysis Report

KTOV Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to KTOV. KTOV may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
KTOV Full Fundamental Analysis Report

KTOV Earnings

Next Earnings DateN/A
Last Earnings DateN/A
KTOV Earnings History

KTOV Forecast & Estimates


Analysts
Analysts100
Price TargetN/A
EPS Next Y86.67%
Revenue Next YearN/A
KTOV Forecast & Estimates

KTOV Financial Highlights

Over the last trailing twelve months KTOV reported a non-GAAP Earnings per Share(EPS) of -3. The EPS increased by 18.92% compared to the year before.


Income Statements
Revenue(TTM)1.00M
Net Income(TTM)-5.85M
Industry RankSector Rank
PM (TTM) -585%
ROA -6.82%
ROE N/A
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)18.92%
Revenue 1Y (TTM)0%
KTOV financials

KTOV Ownership

Ownership
Inst Owners30.72%
Shares15.72M
Float9.97M
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
KTOV Ownership

About KTOV

Company Profile

Kitov Pharmaceuticals Holdings Ltd. is a pharmaceutical company which focused on the development of therapeutic candidates. The company's product candidate consists of KIT-302, is formulated for treatment of pain caused by osteoarthritis and hypertension, which can be pre-existing or caused by the treatment for OA. Kitov Pharmaceuticals Holdings Ltd. is based in Jerusalem, Israel.

Company Info

Kitov Pharma Ltd

ONE AZRIELI CENTER ROUND TOWER 132 MENACHEM BEGIN ROAD

TEL AVIV L3 6701101

CEO: Isaac Israel

Phone: 972-3933-3121

Kitov Pharma Ltd / KTOV FAQ

What does Kitov Pharma Ltd do?

Kitov Pharmaceuticals Holdings Ltd. is a pharmaceutical company which focused on the development of therapeutic candidates. The company's product candidate consists of KIT-302, is formulated for treatment of pain caused by osteoarthritis and hypertension, which can be pre-existing or caused by the treatment for OA. Kitov Pharmaceuticals Holdings Ltd. is based in Jerusalem, Israel.


What is the stock price of Kitov Pharma Ltd today?

The current stock price of KTOV is 4.17 null. The price increased by 2.21% in the last trading session.


Does KTOV stock pay dividends?

KTOV does not pay a dividend.


How is the ChartMill rating for Kitov Pharma Ltd?

KTOV has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


What is Kitov Pharma Ltd worth?

Kitov Pharma Ltd (KTOV) has a market capitalization of 65.57M null. This makes KTOV a Micro Cap stock.